All articles by Surya Rao Akella
Surya Rao Akella
Otsuka signs collaboration deal to bring ABILIFY MYCITE system to US
The Collaboration Agreement creates the opportunity for physicians and adult patients to gather experience in a real-world setting with the…
AtriCure achieves milestone with Afib therapy
AtriCure claims that the study is the first prospective, randomized trial comparing the Convergent approach to endocardial catheter ablation in…
FDA approves Ceterix Orthopaedics’ new suture cartridge
Ceterix, which is based in Fremont, California, is backed by investors Versant Ventures, 5AM Ventures and CRG. The clearance is…
Titan Medical secures US patent for instrument insertion in single-port robotic surgery
The U.S. Patent No. 10,058,396 is titled “System and Apparatus for Insertion of an Instrument Into a Body Cavity for…
Teleflex enrolls first patient in US clinical study of CleanSweep closed suction system
The study is being carried out at Duke University Hospital in Durham, North Carolina. CleanSweep Closed Suction System utilizes the…
Corvia Medical’s interatrial shunt study meets primary endpoint
The interatrial shunt device is claimed to be the world’s first transcatheter device for heart failure with preserved (HFpEF) and mid-range…
Two studies validate continued accuracy improvements of Cognoa’s AI platform in autism children
Cognoa said the data offers the foundation for continued clinical validation of its technology on its path toward becoming a…
ALRT signs MOU with Aspire Cerebro to bring diabetes solution to India
The arrangement would connect private healthcare facilities in India with global pharmaceuticals companies and glucose test suppliers through the ALRT…
LifeHealthcare to distribute 7D Surgical’s image guidance technologies
LifeHealthcare is a leading independent provider of medical devices and healthcare solutions in Australia and New Zealand. 7D Surgical develops…
Curium, RadioMedix to develop PET diagnostic agent for NETs patients
Presently, RadioMedix is conducting the Phase III clinical trials of the agent. The company expects to submit a new drug…